In the BioHarmony Drug Report Database
Quinethazone
Hydromox (quinethazone) is a small molecule pharmaceutical. Quinethazone was first approved as Hydromox on 1982-01-01. It is used to treat edema, heart failure, hypertension, and nephrotic syndrome in the USA.
Trade Name
|
Hydromox |
|---|---|
Common Name
|
quinethazone |
ChEMBL ID
|
CHEMBL1532 |
Indication
|
edema, heart failure, hypertension, nephrotic syndrome |
Drug Class
|
Image (chem structure or protein)